Low-methoxy pectin-containing enteral nutrition in critical care for intestinal tolerance (LOME-PECT): Study protocol for a randomized controlled trial

S Shizuka Kashiwagi S Shunsuke Takaki Y Yasufumi Oi H Hiroshi Honzawa R Ryo Yamamoto I Ikutaro Yamashita I Izumi Ohki S Shigeki Fujitani A Akiyoshi Nagatomi Y Yuki Ohshima M Minoru Yoshida (Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo) H Hideki Yoshida (Institute of Fermentation Sciences, Fukushima University) M Miyuki Kurisu Y Yuji Takahashi H Hideki Hashimoto (Department of Applied Chemistry, School of Advanced Engineering, Kogakuin University, 2665-1 Nakano, Hachioji, Tokyo 192-0015, Japan) Y Yasuaki Koyama J Junji Hatakeyama S Satoru Shinoda N Nobuyuki Yokoyama K Kensuke Nakamura

Abstract

Background Enteral nutrition is preferable over parenteral nutrition for critically ill patients, but is often discontinued due to enteral feeding intolerance. Diarrhea is one of the most common causes of the discontinuation of enteral nutrition and may be attributed to the composition of enteral formulas. Dietary fiber attenuates diarrhea by normalizing the intestinal microbiota, providing energy for colonic epithelial cells, and exerting a thickening effect on intestinal contents. We herein conducted a randomized controlled trial (RCT) to test the hypothesis that the administration of an enteral formula containing low-methoxy pectin, a type of dietary fiber, more effectively ameliorates diarrhea in critically ill adult patients than a similar composition without pectin. Methods A protocol for planning a multicenter, parallel-group, open-label RCT is described herein. Enrolled patients are those ≥18 years of age with the indication of enteral nutrition by gastric access. Overall, 200 patients will be randomized into an intervention group administered an enteral formula containing low-methoxy pectin and a control group administered an enteral formula with similar components, but without pectin at a ratio of 1:1. Each enteral formula will be administered for 3 days or longer. There are no restrictions on other treatments. The primary outcome is the incidence of diarrhea as defined by Bristol Scale 5, 6, or 7. Secondary outcomes include the rate of EN failure, the survival rate, the lengths of ICU and hospital stays, and nutritional endpoints. Discussion The present study examines the effects of a low-methoxy pectin-containing enteral formula on enteral feeding intolerance, including diarrhea, in critically ill patients. The results obtained may provide new considerations regarding the selection of enteral formulas for critically ill patients. Trial registration jRCTs031230684 registered on 08 Mar 2024, https://jrct.niph.go.jp/en-latest-detail/jRCTs031230684.

Article Details

Journal PLoS ONE
Volume / Issue Vol. 20, Issue 7
Published July 11, 2025
Pages e0326582
ISSN 1932-6203
Publisher Public Library of Science

Journal Info

PLoS ONE

Public Library of Science

ISSN: 1932-6203 Open Access Health Sciences

Authors (20)

S

Shizuka Kashiwagi

S

Shunsuke Takaki

Y

Yasufumi Oi

H

Hiroshi Honzawa

R

Ryo Yamamoto

I

Ikutaro Yamashita

I

Izumi Ohki

S

Shigeki Fujitani

A

Akiyoshi Nagatomi

Y

Yuki Ohshima

M

Minoru Yoshida

Department of Biotechnology, Graduate School of Agricultural and Life Sciences, The University of Tokyo

H

Hideki Yoshida

Institute of Fermentation Sciences, Fukushima University

M

Miyuki Kurisu

Y

Yuji Takahashi

H

Hideki Hashimoto

Department of Applied Chemistry, School of Advanced Engineering, Kogakuin University, 2665-1 Nakano, Hachioji, Tokyo 192-0015, Japan

Y

Yasuaki Koyama

J

Junji Hatakeyama

S

Satoru Shinoda

N

Nobuyuki Yokoyama

K

Kensuke Nakamura